AU2002328441A1 - Novel antisense oligonucleotide derivatives to hepatitis c virus - Google Patents

Novel antisense oligonucleotide derivatives to hepatitis c virus

Info

Publication number
AU2002328441A1
AU2002328441A1 AU2002328441A AU2002328441A AU2002328441A1 AU 2002328441 A1 AU2002328441 A1 AU 2002328441A1 AU 2002328441 A AU2002328441 A AU 2002328441A AU 2002328441 A AU2002328441 A AU 2002328441A AU 2002328441 A1 AU2002328441 A1 AU 2002328441A1
Authority
AU
Australia
Prior art keywords
hepatitis
virus
antisense oligonucleotide
oligonucleotide derivatives
novel antisense
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002328441A
Inventor
Takeshi Imanishi
Satoshi Obika
Yoshiyuki Ohsugi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002328441A1 publication Critical patent/AU2002328441A1/en
Abandoned legal-status Critical Current

Links

AU2002328441A 2001-09-17 2002-09-17 Novel antisense oligonucleotide derivatives to hepatitis c virus Abandoned AU2002328441A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001-282111 2001-09-17

Publications (1)

Publication Number Publication Date
AU2002328441A1 true AU2002328441A1 (en) 2003-04-01

Family

ID=

Similar Documents

Publication Publication Date Title
AU2171501A (en) Improvements relating to double-stranded rna inhibition
AU2001269700A1 (en) Heterocycle carboxamides as antiviral agents
AU2001269697A1 (en) Heterocycle carboxamides as antiviral agents
AU2001282522A1 (en) Novel nucleoside analogs and oligonucleotide derivatives containing these analogs
AU2001295732A1 (en) Concatenated nucleic acid sequences
AU2002341989A1 (en) Process to produce derivatives from uk-2a derivatives
EP1299351A4 (en) Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
AUPR621501A0 (en) Delivery of ds rna
AU2001269699A1 (en) Heterocycle carboxamides as antiviral agents
AU2002358700A1 (en) Urea derivatives as vr1- antagonists
HUP0302593A3 (en) Self-replicating rna molecule from hepatitis c virus
GB0017720D0 (en) Modified virus
AU2002225895A1 (en) Hepatitis c virus constructs characterized by high efficiency replication
IL157251A0 (en) Hepatitis b virus treatment
AUPP967999A0 (en) Viral variants
AU2292600A (en) Varicella-zoster virus vaccines
AU2003281867A1 (en) Antisense nucleic acids
EP1437408A4 (en) Novel antisense oligonucleotide derivatives against hepatitis c virus
AU2002310296A1 (en) Rna purification methods
AU6551800A (en) Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptasesand viruses
AU2002328441A1 (en) Novel antisense oligonucleotide derivatives to hepatitis c virus
AU2001285257A1 (en) Human telomerase rna elements
WO2002083858A8 (en) Methods to inhibit viral replication
AU2001254670A1 (en) Detection of hepatitis b virus rna
AU2003266243A8 (en) 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors